e-learning
resources
Stockholm 2002
Monday 16.09.2002
Thoracic oncology: biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gene expression mapping to diagnose malignant mesothelioma
R. Wiewrodt, S. Singhal, L. Malden, K. Matzie, J. Kucharczuk, J. Friedberg, L. R. Kaiser, S. M. Albelda (Philadelphia, United States Of America; Mainz, Germany)
Source:
Annual Congress 2002 - Thoracic oncology: biology
Session:
Thoracic oncology: biology
Session type:
Poster Discussion
Number:
1514
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Wiewrodt, S. Singhal, L. Malden, K. Matzie, J. Kucharczuk, J. Friedberg, L. R. Kaiser, S. M. Albelda (Philadelphia, United States Of America; Mainz, Germany). Gene expression mapping to diagnose malignant mesothelioma. Eur Respir J 2002; 20: Suppl. 38, 1514
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004
CXCL12 expression in malignant mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 138s
Year: 2007
Expression of c-met in malignant pleural mesothelioma; an immunohistochemical study
Source: Annual Congress 2007 - Inorganic dust "old timers and new kids on the block"
Year: 2007
Evaluating the role of muc4 expression in the differential diagnosis of mesothelioma and adenocarcinoma of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 81s
Year: 2006
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Soluble mesothelin as a monitoring tool for malignant mesothelioma patients
Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Year: 2009
Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
BAP1 expression and treatment outcomes in malignant mesothelioma.
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017
Differential gene expression of two-pore-domain potassium channels in malignant pleural mesothelioma
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008
Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Effect of asbestos on gene expression of tight junctions components in malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Diagnostic value of common MAGE RT-PCR in malignant pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002
(Array)CGH analysis of chromosomal gains and losses in human malignant pleural mesothelioma cell lines: Involved loci and genes
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Prognostic impact of histology and treatment modalities in malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Management of malignant mesothelioma
Source: ERS Skills Course 2018 - Practical Pleural Skills
Year: 2018
Gene expression profiling of lung adenocarcinoma by microarray analysis
Source: Eur Respir J 2005; 26: Suppl. 49, 93s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept